ACSS2

ACSS2製品

All (4)
ACSS2阻害剤 (4)
新製品

製品コード	製品名称	製品説明	文献中Selleckの製品使用例
S8588	ACSS2 inhibitor	ACSS2 inhibitor is the most potent and specific inhibitor of acetate-dependent acetyl-CoA synthetase 2 (ACSS2). ACSS2 inhibitor also inhibits the respiratory syncytial virus (RSV).	Nat Commun, 2024, 15(1):3200 Research (Wash D C), 2024, 7:0400 Cell Commun Signal, 2024, 22(1):187
E1931^New	AD-5584	AD-5584 is a specific inhibitor of human acyl-CoA synthetase short chain family member 2 (ACSS2). It significantly reduces lipid storage, decreases colony formation, and increases cell death in vitro, while also confirming blood-brain barrier (BBB) permeability.
E1147	VY-3-135	VY-3-135, a potent ACSS2 inhibitor with IC50 of 44 ± 3.85 nM, potently inhibits ACSS2 dependent fatty acid metabolism but has no effect on gene expression in tumors.	Cancers (Basel), 2024, 16(5)1035
E1211	MTB-9655	MTB-9655 is a novel, potent and selective Acetyl-Coenzyme A Synthetase 2 (ACSS2) inhibitor, which is currently in Phase I clinical investigation on patients with tumors with high levels of ACSS2.
S8588	ACSS2 inhibitor	ACSS2 inhibitor is the most potent and specific inhibitor of acetate-dependent acetyl-CoA synthetase 2 (ACSS2). ACSS2 inhibitor also inhibits the respiratory syncytial virus (RSV).	Nat Commun, 2024, 15(1):3200 Research (Wash D C), 2024, 7:0400 Cell Commun Signal, 2024, 22(1):187
E1931^New	AD-5584	AD-5584 is a specific inhibitor of human acyl-CoA synthetase short chain family member 2 (ACSS2). It significantly reduces lipid storage, decreases colony formation, and increases cell death in vitro, while also confirming blood-brain barrier (BBB) permeability.
E1147	VY-3-135	VY-3-135, a potent ACSS2 inhibitor with IC50 of 44 ± 3.85 nM, potently inhibits ACSS2 dependent fatty acid metabolism but has no effect on gene expression in tumors.	Cancers (Basel), 2024, 16(5)1035
E1211	MTB-9655	MTB-9655 is a novel, potent and selective Acetyl-Coenzyme A Synthetase 2 (ACSS2) inhibitor, which is currently in Phase I clinical investigation on patients with tumors with high levels of ACSS2.
E1931^New	AD-5584	AD-5584 is a specific inhibitor of human acyl-CoA synthetase short chain family member 2 (ACSS2). It significantly reduces lipid storage, decreases colony formation, and increases cell death in vitro, while also confirming blood-brain barrier (BBB) permeability.

ACSS2阻害剤の選択性比較